Xenograft of human umbilical mesenchymal stem cells from Wharton’s jelly as a potential therapy for rat pilocarpine-induced epilepsy  by Huang, Pei-Yu et al.
Brain, Behavior, and Immunity 54 (2016) 45–58Contents lists available at ScienceDirect
Brain, Behavior, and Immunity
journal homepage: www.elsevier .com/locate /ybrbiFull-length ArticleXenograft of human umbilical mesenchymal stem cells from Wharton’s
jelly as a potential therapy for rat pilocarpine-induced epilepsyhttp://dx.doi.org/10.1016/j.bbi.2015.12.021
0889-1591/ 2015 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
⇑ Corresponding authors at: Department of Anatomy, School of Medicine,
National Yang-Ming University, 155 Sec. 2, Li-Nung Street, 112, Taipei, Taiwan.
(Y.-S. Fu), Institute of Brain Science, National Yang-Ming University, No. 155, Sec. 2,
Li-Nung Street, 112, Taipei, Taiwan. (Y.-Y. Lin).
E-mail addresses: ysfu@ym.edu.tw (Y.-S. Fu), g2000kev@gmail.com (Y.-Y. Lin).Pei-Yu Huang a,b, Yang-Hsin Shih c,d, Yi-jhan Tseng e, Tsui-Ling Ko f, Yu-Show Fu g,h,⇑,
Yung-Yang Lin a,b,i,j,k,l,m,⇑
a Institute of Physiology, National Yang-Ming University, Taipei, Taiwan
b Laboratory of Neurophysiology, Taipei Veterans General Hospital, Taipei, Taiwan
cDepartment of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan
dDepartment of Anatomy, School of Medicine, Taipei Medical University, Taipei, Taiwan
eDivision of medical research, MacKay Memorial Hospital, HsinChu Branch, Taiwan
fDepartment of Optometry, Shu-Zen College of Medicine and Management, Kaohsiung City, Taiwan
gDepartment of Anatomy and Cell Biology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
hDepartment of Education and Research, Taipei City Hospital, Taipei, Taiwan
i Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan
j Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
kBrain Research Center, National Yang-Ming University, Taipei, Taiwan
l School of Medicine, National Yang-Ming University, Taipei, Taiwan
mDepartment of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan
a r t i c l e i n f o a b s t r a c tArticle history:
Received 27 May 2015
Received in revised form 15 December 2015
Accepted 24 December 2015
Available online 28 December 2015
Keywords:
Human umbilical mesenchymal stem cells
Wharton’s jelly
Temporal lobe epilepsy
Status epilepticus
PilocarpineWe evaluated the effects of intra-hippocampal transplantation of human umbilical mesenchymal stem
cells (HUMSCs) on pilocarpine-treated rats. Sprague–Dawley rats were divided into the following three
groups: (1) a normal group of rats receiving only PBS, (2) a status epilepticus (SE) group of rats with
pilocarpine-induced SE and PBS injected into the hippocampi, and (3) a SE + HUMSC group of SE rats with
HUMSC transplantation. Spontaneous recurrent motor seizures (SRMS) were monitored using simultane-
ous video and electroencephalographic recordings at two to four weeks after SE induction. The results
showed that the number of SRMS within two to four weeks after SE was significantly decreased in SE
+ HUMSCs rats compared with SE rats. All of the rats were sacrificed on Day 29 after SE. Hippocampal
morphology and volume were evaluated using Nissl staining and magnetic resonance imaging. The
results showed that the volume of the dorsal hippocampus was smaller in SE rats compared with normal
and SE + HUMSCs rats. The pyramidal neuron loss in CA1 and CA3 regions was more severe in the SE rats
than in normal and SE + HUMSCs rats. No significant differences were found in the hippocampal neuronal
loss or in the number of dentate GABAergic neurons between normal and SE + HUMSCs rats. Compared
with the SE rats, the SE + HUMSCs rats exhibited a suppression of astrocyte activity and aberrant mossy
fiber sprouting. Implanted HUMSCs survived in the hippocampus and released cytokines, including FGF-
6, amphiregulin, glucocorticoid-induced tumor necrosis factors receptor (GITR), MIP-3b, and osteoprote-
gerin. In an in vitro study, exposure of cortical neurons to glutamate showed a significant decrease in cell
viability, which was preventable by co-culturing with HUMSCs. Above all, the expression of human osteo-
protegerin and amphiregulin were significantly increased in the media of the co-culture of neurons and
HUMSCs. Our results demonstrate the therapeutic benefits of HUMSC transplantation for the develop-
ment of epilepsy, which are likely due to the ability of the cells to produce neuroprotective and anti-
inflammatory cytokines. Thus, HUMSC transplantation may be an effective therapy in the future.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Temporal lobe epilepsy (TLE) is a chronic disease characterized
by spontaneous, progressive seizures. In many patients, TLE is ini-
tiated by brain injury, strokes, tumors or status epilepticus (SE),
which is often followed by a latency period of 5–10 years before
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and Lowenstein, 2003; O’Dell et al., 2012; Sharma et al., 2007).
SE is defined as a continuous seizure activity lasting more than
5 min (Brophy et al., 2012). SRMS is the repeated unprovoked sei-
zures that occurs in the chronic phase of epilepsy (Hattiangady and
Shetty, 2008). The main physiopathological findings observed in
TLE are neuronal loss, reactive gliosis, aberrant mossy fiber sprout-
ing and spontaneous recurrent motor seizure (SRMS) (Acharya
et al., 2008; Carpentino et al., 2008; Rao et al., 2006). Antiepileptic
drugs fail to well-control seizures in approximately 30% of epilepsy
patients. Stem cell grafting is considered to be a promising alterna-
tive approach for a better treatment of epilepsy (French et al.,
2004; Nilsen and Cock, 2004).
There are two possible mechanisms of stem cell transplantation
in the treatment of epilepsy. In one mechanism, the transplanted
stem cells may replace the cells lost by trans-differentiation. Stem
cells possess self-renewal properties, and the ability to differenti-
ate into different cell types, which may replace lost cells or specific
neurons during epilepsy, such as inhibitory interneurons (Roper
and Steindler, 2013). On the other hand, neuroprotective or anti-
inflammatory cytokines are released from stem cells, which are
involved in the repair of autoimmune encephalomyelitis, amy-
otrophic lateral sclerosis, stroke and spinal cord injury (Einstein
et al., 2007; Lin et al., 2011; Vercelli et al., 2008; Yang et al.,
2008). To date, using stem cells to replace the cells that are lost
during the course of epileptogenesis has been considered an effec-
tive strategy in the treatment of epilepsy (Cunningham et al., 2014;
Hunt et al., 2013). However, little is known on the exact trophic
mechanisms of stem cell therapy in epilepsy.
Human mesenchymal cells from Wharton’s jelly of the umbili-
cal cord are obtained from medical waste after delivery and there-
fore carry little ethical concerns. These human umbilical
mesenchymal stem cells (HUMSCs) can differentiate into neuro-
genic, osteogenic, chondrogenic, adipogenic, and myogenic cells
in vitro (Fu et al., 2004; Mitchell et al., 2003; Wang et al., 2004).
Our previous studies have shown that the engrafted HUMSCs are
viable in ischemia cortex, striatum, and spinal cord of rats without
the need for immunological suppression (Fu et al., 2006; Lin et al.,
2011; Yang et al., 2008). HUMSC transplantation effectively pro-
tects neurons from atrophy, prevents inflammation, and amelio-
rates motor performance deterioration, which is likely due to the
ability of the cells to produce growth-promoting factors (Lin
et al., 2011; Yang et al., 2008). In addition to their effects in the
central nervous system, HUMSC transplants in rats with liver fibro-
sis and peritoneal fibrosis also exhibit promising therapeutic
potentials by means of cytokine release (Tsai et al., 2009). These
results indicate that HUMSCs possess the ability of long-term sur-
vival, and maintain their functions within various host organs of
the rat, suggesting that HUMSCs are a good stem cell source for
xenotransplantation.
To evaluate whether HUMSC transplantation at the acute phase
of brain damage prevents or alleviates chronic epilepsy, HUMSCs
were isolated from Wharton’s jelly of human umbilical cords and
transplanted into hippocampi of pilocarpine-treated rats. We then
investigated the effects HUMSCs of on seizure frequency and dura-
tion and cognitive outcome in chronic epilepsy. The results showed
that the transplanted cells remained viable and functional for one
month, effectively ameliorating the hippocampal injury, decreas-
ing glial activation, and suppressing circuitry reorganization.2. Materials and methods
The use of human umbilical cord and laboratory animals in this
study was approved by the Research Ethics Committee at TaipeiVeterans General Hospital and the Animal Research Committee
of the College of Medicine at National Yang-Ming University.
2.1. Animals
Six-week-old male Sprague–Dawley rats (230–270 g) were used
in this study. All of the rats were sacrificed four weeks after sur-
gery. All of the animals were kept in individual cages under envi-
ronmentally controlled conditions (12-h light/dark cycle) and
were given food and drinking water ad libitum. The animals were
divided into the three following groups: (1) the normal group,
where rats received only an intraperitoneal injection of the phos-
phate buffer saline vehicle (PBS; pH 7.4) in place of pilocarpine
(n = 16); (2) the status epilepticus group (referred to as the SE
group), where SE in rats was induced by an intraperitoneal injec-
tion of pilocarpine in PBS (n = 28); and (3) the SE + HUMSCs group,
where rats received both pilocarpine and transplanted HUMSCs
(n = 32).
2.2. Isolation and preparation of HUMSCs
Human umbilical cords were collected in Hanks’ balanced salt
solution (HBSS) (14185-052; Gibco) at 4 C. Following disinfection
with 75% ethanol for 30 s, the umbilical cord vessels were cleared
off in HBSS. The mesenchymal tissues in Wharton’s jelly were then
diced into cubes of 0.5 cm in length on each side, and centrifuged
at 250g for 5 min. After removal of the supernatant fraction, the
precipitate containing the mesenchymal tissue was washed with
serum-free Dulbecco’s modified Eagle’s medium (DMEM) (12100-
046; Gibco) and centrifuged again at 250g for another 5 min.
After aspirating off the supernatant fraction, the mesenchymal tis-
sue in the precipitate was treated with collagenase (17100-017;
Gibco) at 37 C for 18 h, washed, and further digested with 2.5%
trypsin (15090-046; Gibco) at 37 C for 30 min. Fetal bovine serum
(FBS) (26140079; Gibco) was added to neutralize the excess
trypsin. The dissociated mesenchymal cells were cultured in 10%
FBS-DMEM.
2.3. Primary culture of rat cortical neurons
The postnatal one-day-old rats were placed under anesthesia,
and cerebral cortices were excised in a sterile laminar flow cham-
ber. The cortices were then collected in a centrifuge tube contain-
ing Ca2+/Mg2+-free Hank’s buffer, and centrifuged at 900 rpm for
5 min. The supernatant was discarded. DMEM containing 10%
FBS was then added to the pellet. The suspension was completely
mixed by triturating 15 times with a sterile glass pipette. The cor-
tical neurons were seeded at a density of 5  103 cells/cm2. To inhi-
bit the growth of glial cells, 20-lM cytosineb-D-arabino-furanoside
(C-6645; Sigma) was added to each well after 24 h. The fetal
serum-containing culture medium was replaced with serum-free
DMEM on the fifth day of culture. The culture systems of cortical
neurons alone or neurons and HUMSCs co-cultures were
performed on Day 5 as well.
2.4. Culture systems of rat cortical neurons alone or neurons and
HUMSCs co-cultures
To explore the effect of HUMSCs on cortical neuron damage that
is induced by glutamate, cortical neurons were cultured alone or
with HUMSCs in a special transwell system. The co-culture system
consisted of upper and lower chambers separated by a distance not
physically traversable by the cells. The chambers, however, shared
the same medium, which covered both cultures, thus allowing
access to both cultures by humoral factors. Forming the bottom
of the upper chamber was a porous membrane with multiple pores
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membrane without the actual mixing of the cells.
Primary HUMSCs were cultured in the upper chamber of the
transwell co-culture system, with cortical neurons cultured in
the lower chamber. The cortical neurons that were cultured alone
or cultured with HUMSCs were cultured in serum-free medium for
two days and then treated with vehicle or 1-mM glutamate for 1 h.
The medium was replaced with new serum-free medium to
remove glutamate, and these cortical neuron and HUMSC cultures
continued for 48 h.
2.5. The assessment of neuron viability
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay measures the mitochondrial activity of viable
cells by quantifying the conversion of the tetrazolium salt to its
formazan product (Aras et al., 2008). Cortical neurons were treated
with MTT solution (final concentration 1 mg/ml; M5655; Sigma) to
determine the proportion of viable cells.
NeuroTrace is a fluorescent Nissl stain that only labels neurons
(Quinn et al., 1995). Cortical neurons were treated with
NeuroTrace solution (N-21480; Molecular Probe) to visualize and
estimate neuron viability (Lazo et al., 2010).
2.6. Quantification of cytokine levels in vitro
Protein samples from the media of neurons alone or neuron and
HUMSC co-cultures lysed in a protein lysis buffer containing phos-
phatase and protease inhibitors were collected for an enzyme-
linked immunosorbent assay (ELISA). Human amphiregulin and
osteoprotegerin in the media were determined using the Quan-
tikine ELISA Kit (ELH-OPG and ELH-AR; RayBiotech) according to
the manufacturer’s protocol.
2.7. Pilocarpine-induced SE
Rats were pretreated with anti-muscarinic drug scopolamine
(1 mg/kg, intraperitoneal; S2250; Sigma) to minimize peripheral
muscarinic effects. Thirty minutes after scopolamine, rats were
injected with pilocarpine (330 mg/kg, intraperitoneally; P6503;
Sigma) to induce SE. Rats developed SE within 5–30 min. To limit
the duration of SE and the extent of the damage in the hippocam-
pus, diazepam (10–20 mg/kg; CCPC) was injected intraperitoneally
90 min after the onset of SE (Biagini et al., 2006). The severity of
convulsive seizures were classified according to Racine’s Scale
(Racine, 1972) as follows: Stage 1, mouth and focal movements;
Stage 2, head nodding; Stage 3, contra-lateral forelimb clonus;
Stage 4, symmetrical forelimb clonus with rearing; and Stage 5,
severe seizure with rearing and falling. All of the surgeries were
performed with the animals under anesthesia with isoflurane (Bax-
ter Healthcare). The rat number totaled 155. Eighty-three out of
155 rats died during SE. Twelve rats displayed Stage 0–1 of the
Racine’s Scale. Sixty rats displaying a minimum of Stage 3 during
this observation period were selected for further experiments in
either the SE or SE + HUMSCs group.
2.8. Transplantation of HUMSCs
One day after SE induction, rats were randomly selected for PBS
injection or cell transplantation. A total of 105 HUMSCs were
stereotaxically injected into the bilateral dorsal hippocampi (AP:
4.8 mm; ML: ±4.8 mm; DV: 7.0 mm; total cell number:
2  105 cells) via a 10-ll Hamilton syringe with a 26-gauge needle.
The syringe was left in place for a fewminutes to minimize backing
up of cells up the needle track (Gage et al., 1995). No immunosup-
pressive medications were administered to any animal in thisstudy. In the SE groups, 5 ll of PBS was injected instead of
HUMSCs.
2.9. Electroencephalography (EEG) monitoring and analysis
EEG/video recordings were employed to monitor spontaneous
motor seizures. At one day after SE induction (n = 6 in SE or SE
+ HUMSCs groups), epidural recording electrodes were implanted
into the right and left lateral parietal association cortices (AP:
4.0 mm, ML: ±3.0 mm) (Wang et al., 2009). After allowing one
week for recovery from surgery, the rats underwent EEG/video
monitoring from two to four weeks post SE. The recording duration
for each rat was 9 h/week (totaling 27 h over three weeks). All of
the EEG analog data were collected using a multi-channel neuro-
physiology system (Plexon Inc.). Simultaneous video recording
was carried out with a camera recorder (Logitech). EEG signals
were redigitalized at 250 Hz and analyzed according to autocorre-
lation methods based on those of White et al. (2006). EEG-detected
spontaneous seizures were further confirmed using simultaneous
video imaging.
2.10. Magnetic resonance imaging (MRI)
T2-weighted images of the hippocampus regions in the rats
(n = 4/group) were taken using a high-resolution 7T MRI system
(Bruker Biospin). MRI was performed on each rat at one week
before SE and one, eight, 15, 22, and 29 days afterwards. Settings
of the images were a field-of-view (FOV) (cm) = 2.5  2.5, thickness
(mm) = 0.5 or 1, a slice sep. (mm) = 0.5 or 1, and a Matrix
size = 256  256 resolution (um). The imaging parameters used
were a number of excitation (NEX) = 12, a TR (ms) = 2522.824 or
3000, and a TE (ms) = 33. Images of serial coronal sections from
dorsal to ventral hippocampi were obtained at 0.5 mm intervals
and analyzed using the software Image J. In the MRIs, white areas
in the hippocampus and lateral ventricles indicated edema.
2.11. Histological and immunohistochemical examinations
At four weeks after the onset of SE, the rats were sacrificed and
transcardially perfused with 4% paraformaldehyde (n = 6, 8, and 9
in normal, SE, and SE + HUMSCs groups, respectively). The brains
were post-fixed in the same fixation solution for 24 h and then in
30% sucrose solution in PBS overnight for cryoprotection. Cryostat
sections were cut at a 30-lm thicknesses with every 10th of the
hippocampal sections selected for histological and immunohisto-
chemical analyses following staining with Nissl or the appropriate
antibodies. For histological examination, hippocampal sections
were incubated in PBS containing 0.5% H2O2 for 20 min to block
endogenous peroxidases. After rinsing in PBS, the specimens were
incubated in blocking solution with 5% normal goat serum and 3%
bovine serum albumin in 0.1 M PBS for 30 min to block any non-
specific binding. Following the removal of the blocking solution,
primary antibodies, including mouse anti-NeuN (MAB377; Milli-
pore Corporation), mouse anti-Parvalbumin (MAB1572; Millipore
Corporation), rabbit anti-GFAP (AB5804, Millipore Corporation)
and mouse anti-ED1 (MAB1435; Millipore Corporation), were
added by dilution in blocking solution to the appropriate concen-
tration and the specimens were incubated overnight at 4 C. Fol-
lowing three washes in PBS, appropriate biotinylated secondary
antibodies were added and allowed to stain for 1 h. Following three
more washes with PBS, the specimens were reacted with an ABC
Complex Kit (PK-4000, Vector Laboratories) at room temperature
for 1 h. Immunolabeled sections were developed with 3,30-
diaminobenzidine tetrahydrochloride hydrate (D5637; Sigma) as
the chromogen with 0.01% H2O2 in 50-mM Tris buffer. Specimens
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Permount (SP15-500; Fisher Scientific).
2.12. Nissl staining
Cryostat sections were mounted on gelatin-coated slides.
Following immersion in 1% Nissl (C5042; Sigma), the sections were
dehydrated in ethanol, cleared in xylene (247642; Sigma), and
coverslipped with Permount.
2.13. Timm’s staining
Timm’s staining is based on the staining of Zn2+-containing
mossy fibers by a sulfide/silver stain. The severity of the MFS were
evaluated based on mossy fiber sprouting in the hippocampus.
Under deep anesthesia, rats (n = 4/group) were perfused with
200 ml of 12% sodium sulfide hydrate (13,468; Sigma) in 0.1 M
sodium phosphate solution (S9638; Sigma), and followed by
200 ml of 2% paraformaldehyde (16,005; Sigma) and 1.25% glutar-
dialdehyde (GL01701000; Scharlau) in 0.1-M phosphate buffer
(PB). Perfused brains were fixed in the same fixation solution for
24 h and thenplaced in 30% sucrose in 0.1-MPBuntil the brains sank
to the bottomof the tubes. Serial coronal sections through the entire
hippocampuswere cut at a thickness of 30-lmwith theaid of a cryo-
stat and processed for Timm’s staining. The sections were stained in
a solution containing 30% gum Arabic (G9752; Sigma), 1.7% hydro-
quinone (H9003; Sigma), 2.3% sodium citrate (S4641; Sigma), 2.5%
citrate acid (C0759; Sigma) and 1.05 mg/ml silver nitrate (S6506;
Sigma) for 1 h (Hsu and Buzsaki, 1993). After washing with H2O,
sections were mounted with Permount.
2.14. Tracing of HUMSCs using bisbenzimide treatment and anti-
human nuclear Ag immunohistochemistry
To trace the viability and distribution of the implanted HUMSCs,
the cells were labeled with 1 g/ml of bisbenzimide (B2883; Sigma)
for 48 h before trypsinization and transplantation. Following sacri-
fice, rats (n = 3) were perfused with 4% paraformaldehyde
(Un2213; Merck) and 7.5% picric acid (925-40; Sigma) in 0.1-M
phosphate buffer (PB). The brain tissues were post-fixed in the
same fixative for 24 h and cryo-protected in 30% sucrose in
0.1-M PB. Following sedimentation, the tissue was embedded in
optimum cutting temperature (OCT) compound, frozen, and cryo-
sectioned at 30-lm in a cryostat (20 C). Frozen sections were
thaw-mounted onto coated glass slides, and directly observed
and photographed under fluorescence microscope. In addition,
immunostaining using anti-human specific nuclear antigen was
performed to trace the survival of HUMSCs. Tissue sections were
first reacted with a primary antibody (MAB1281; Millipore Corpo-
ration) and at 4 C for 18 h, washed with 0.1-M PBS, and reacted
with secondary antibodies (biotin-conjugated goat anti-mouse-
IgG; Sigma) at room temperature for 1 h. After the chromogenic
reaction, the sections were coverslipped and observed under a
microscope.
2.15. Human cytokine array
To elucidate which human cytokines were involved in the
suppression of the SRMS, a human protein cytokine kit
(AAH-CYT-2000, RayBio Human Cytokine Antibody Array C Series
2000, RayBiotech) was used to screen the expression of 174 human
cytokines (n = 3/group). Rats were deeply anesthetized and decap-
itated at 28 days after HUMSC transplantation. Hippocampi were
homogenized in lysis buffer and centrifuged at 1500g to separate
cell debris. The supernatant was harvested and then incubated for
2 h at room temperature with membranes containing an array ofhuman cytokine antibodies. The levels of cytokine expression were
determined by the intensities of immunoreactivity as relative to
that of the standard controls using enhanced chemiluminescence
according to the manufacturer’s instructions.
2.16. Reverse transcription PCR for detecting human NeuN and GFAP in
the hippocampus
Total RNA was freshly isolated from the rat hippocampi using
the TRIzol Reagent (Invitrogen) (n = 3/group), and reverse tran-
scribed into complementary DNA with SuperScript III (18,080,
Invitrogen). Specific primers for PCR were designed to detect only
human NeuN and GFAP with primer express software (Vector NTI
Software, Invitrogen). PCR products were amplified with 35 cycles
of 94 C for 30 s, 58 C for 30 s, and 72 C for 30 s), and resolved on
a 2% agarose gel. Human hippocampus was used as a positive con-
trol. The primer sequences were as follows:
Human NeuN
Sense: 50-ATCCAGTGGTCGGCGCAGTCTAC-30
Antisense: 50-TACGGGTCGGCAGCTGCGTA-30
Human GFAP
Sense: 50-TCCACTTCCTCCTCCTCCACGA-30
Antisense: 50-AACTTGCACACGGCGCAGGT-30
Human GAPDH
Sense: 50-TTCCACCCATGGCAAATTCCATGG-30
Antisense: 50-GGTCAGGTCCACCACTGACACG-30
Rat GAPDH
Sense: 50-CTCTACCCACGGCAAGTTCAAC-30
Antisense: 50-GGTGAAGACGCCAGTAGACTCCA-30
Human and rat b-actin (Jones et al., 1999; Kowalewski et al.,
2010)
Sense: 50-TTGTAACCAACTGGGACGATATGG-30
Antisense: 50-GATCTTGATCTTCATGGTGCTAGG-30
2.17. Quantification and statistical analyses
The statistics software SPSS 17.0wasused for statistical analyses.
Data were expressed as the mean ± SEM for each group. Data were
analyzed by an ANOVA followed by post hoc Bonferroni analyses.
Differences were considered statistically significant when p < 0.05.
3. Results
3.1. HUMSC transplantation attenuated the incidence and duration of
spontaneous recurrent seizures in the chronic phase
To examine the effects of HUMSC transplantation on
pilocarpine-induced SE, seizures were monitored both by video
and EEG recordings from two to four week after PBS injection or
HUMSC implantation. SE induced in the pilocarpine treated rats
was characterized by continuous motor-limbic seizures lasting in
excess of 90 min. Surface EEG that was recorded from the brain
cortex showed seizure spikes during SRMS in both the SE and SE
+ HUMSCs groups (Fig. 1A and B), with convulsive seizure detec-
tion based on the effective algorithms designed by White AM
(White et al., 2006). The results indicated that the percentages of
occurrence were significantly different between the two groups
with five out of six (83%) rats in the SE groups developing SRMS,
while only three out of six (50%) rats in the SE + HUMSCs group
developed SRMS. The onset of the seizure was also delayed by
HUMSCs transplantation from the 2nd week after pilocarpine
treatment in the SE rats to the 3rd week in the SE + HUMSCs rats
(Fig. 1C). Significant differences were also present between the
two groups in incidence and duration. The total number of seizures
in the SE rats was significantly greater by 5.33 ± 1.52 compared
10 sec
1 
m
V
1 
m
V
1 sec
A
B
C
D
E
Fig. 1. Antiepileptic effects of HUMSC transplantation on pilocarpine-induced SE. Representative EEG tracings of SE (A) and SE + HUMSC (B) rats. Incidence (C), total numbers
(D) and duration (E) of spontaneous seizures between the 2nd and 4th weeks in the two groups of rats. HUMSC transplantation significantly decreased all of these measures.
*p < 0.05, compared with SE rats at the same day. #p < 0.05, compared with the value obtained in the 2nd week in the SE group. N p < 0.05, compared with the value observed
in the 3rd week in the SE group.
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durations were also significantly longer in the SE rats than in the
SE + HUMSCs rats (Fig. 1E). Taken together, HUMSCs transplanta-
tion attenuated pilocarpine-induced SE in terms of onset, inci-
dence, and duration.
3.2. HUMSCs transplantation reduced brain edema in chronic epilepsy
Other pathological changes after pilocarpine-induced SE such as
brain edema were evaluated using MRI (Fig. 2A and B). There were
hardly any detectable edema areas in the rat brain before pilo-
carpine injection (pictures not shown). In the SE group, brain
edema appeared in the hippocampus, lateral ventricles, thalamus,
and piriform cortex one day after SE. Significantly increased edema
was found in the hippocampus, lateral ventricles, and the 3rd ven-
tricle eight days after SE induction. Brain edema reached a plateau
at 15 days and persisted up to 29 days in the SE group (Fig. 2A). In
SE + HUMSCs group, lateral ventricle edema appeared one day after
SE; however, brain edema at eight days was similar to that at one
day. Starting from 15 days after SE, edema in the ventricle and hip-
pocampus were increased and persisted up to 29 days in the SE
+ HUMSCs group (Fig. 2B). In addition, HUMSCs transplantation
significantly attenuated the edema in the ventricles, hippocampus,
and piriform cortex on Days 8 and 29 post-SE (Fig. 2D). In
summary, the brain edema was attenuated significantly by the
transplantation of HUMSCs into the rat hippocampi.
3.3. HUMSC transplantation reduced hippocampal cytoarchitecture
changes in chronic epilepsy
Possible changes in the cytoarchitecture associated with pilo-
carpine were examined histo-morphologically on Nissl stained
coronal sections that were obtained following the sacrifice of therats 29 days after pilocarpine-induced SE. Consistent with MRI T2
signal results, the lateral ventricles were significantly enlarged in
the SE group than those in the SE + HUMSC group (Fig. 2C). Mor-
phology of the dorsal hippocampus was abnormal, and the dorsal
hippocampal volume in the SE group was significantly decreased
compared with those in the other two groups (Fig. 2C and E). There
was no significant difference in hippocampal volume between the
normal and the SE + HUMSC groups (Fig. 2E), suggesting a protec-
tive role for the transplanted HUMSCs in preventing brain edema
and hippocampal atrophy resulting from pilocarpine-induced SE.3.4. HUMSCs transplantation preserved the integrity of the
hippocampal pyramidal neurons and inhibitory circuitry in chronic
epilepsy
The effects of pilocarpine treatment and HUMSCs transplanta-
tion on the neuronal circuitry in the hippocampus were evaluated
immunohistochemically by staining the pyramidal and GABAergic
interneurons with anti-NeuN and anti-parvalbumin. Quantitative
calculation of pyramidal neurons in the dorsal hippocampus
demonstrated that the number of pyramidal neurons was
decreased in the CA1 and CA3 regions in the SE compared with
those of the normal group (Fig. 3A, B, and G). The loss of pyramidal
neurons in the CA1 and CA3 regions induced by pilocarpine injec-
tion was attenuated by HUMSC transplantation (Fig. 3C and G).
There was barely a detectable change in the number of hilar cells
in the dentate gyrus in all three groups (Fig. 3G).
Compared with the normal rats, pilocarpine-induced SE caused
loss of GABAergic interneurons in the hippocampal CA1 and CA3
regions (Fig. 3D, E, and H). Such losses were attenuated by HUMSC
transplantation (Fig. 3F and H). These results suggest that HUMSCs
transplantation exhibited neuroprotective effects on the surviving
pyramidal cells and inhibitory interneurons.
Day1 Day8 Day15 Day22 Day29
A
B
D
E
Day1 Day8 Day15 Day22 Day29
C
Fig. 2. Brain edema examined using MRI and Nissl staining. Magnetic resonance imaging T2-weighted images obtained from SE (A) and SE + HUMSC rats (B). (A) T2-weighted
signals showing increases in the hippocampus one day after SE. Hippocampal and ventricular edema becoming apparent in SE group at eight days following a SE induction. (B)
HUMSC transplantation delayed the appearance of edema following SE. (D) Quantitative data between SE and SE + HUMSC rats showing an effective reduction of brain edema
in the lateral ventricles and a partial hippocampal region for the HUMSC transplanted group. * < 0.05, the edema volume compared with the value obtained at one day after SE
in the same group. N p < 0.05, the edema volume compared with the value obtained at eight days after SE in the same group. #p < 0.05, edema volume compared with SE group
at the same day. (C) Cytoarchitecture of the hippocampus by Nissl staining in normal, SE and SE + HUMSC rats 29 days after pilocarpine-induced SE. (E) Dorsal hippocampal
volume was calculated using Nissl staining. In comparison to the normal hippocampus, SE rats showed a lateral ventricle edema and dorsal hippocampal atrophy, which was
prevented by HUMSC transplantation. * < 0.05, compared with the normal group. #p < 0.05, comparison between the SE and SE + HUMSC groups. Scale bars = 200 lm (C).
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activation in the chronic epilepsy
To further investigate the effects of transplanted HUMSCs
on brain inflammation induced by pilocarpine-induced SE, theexpression of astrocyte and microglial cells in the three groups
were evaluated. In the normal brain, astrocytes are only minimally
activated (Fig. 4A and D). The fiber density of astrocytes was signif-
icantly increased in the hippocampal CA1, CA3, and dentate gyrus
regions only in the SE group (Fig. 4B and D). The levels of astrocyte
DE
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Fig. 3. HUMSCs transplantation alleviates pyramidal neurons and interneurons loss in the hippocampus after pilocarpine-induced SE. The distribution of pyramidal neurons
in the hippocampal regions as visualized using anti-NeuN immunostaining in normal rats (A), SE (B) and SE + HUMSC rats (C) at 29 days after SE. (G) Bar graphs showing the
number of pyramidal neurons in the hippocampal regions in the three groups. HUMSC transplantation attenuated SE-induced neuronal losses in the CA1 and CA3 regions (A–
C). No significant differences between the three groups were observed in the DH region (A–C). Photomicrographs showing the distribution of GABAergic inhibitory
interneurons as visualized using anti-parvalbumin in the normal (D), SE (E) and SE + HUMSC rats (F). (H) Histograms showing the number of parvalbumin positive neuronal
soma in hippocampal regions in the three groups of rats. HUMSC transplantation attenuated SE-induced parvalbumin-positive cell loss in the CA1 and CA3 regions. No
significant differences between the three groups were observed in the DH region. Scale bars = 500 lm (A–F); 100 lm (in CA1, CA3, and DH). * < 0.05, compared with normal
rat in the same region. #p < 0.05, comparison between SE and SE + HUMSC groups.
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rats (Fig. 4A and C). Transplanted HUMSCs effectively reduced
the pilocarpine-induced astrogliosis (Fig. 4D).
In the normal brain, microglial cells were scarcely detected (pic-
tures not shown). Marked ED1 revealed significantly more acti-
vated microglial cells in the hippocampus of the SE group
(Fig. 4E and F).
In the SE + HUMSCs group, there were some activated micro-
glial cells in the hippocampus. There were fewer activated micro-
glial cells after stem cell transplantation compared with those of
the SE group (Fig. 4G and H). These results demonstrated that
HUMSCs transplantation suppressed pilocarpine-induced
astrogliosis and brain inflammation.3.6. HUMSCs transplantation attenuated mossy fiber sprouting in
chronic epilepsy
To investigate whether pilocarpine-induced SE changes the
neuronal circuitry, Timm’s staining was used to monitor mossy
fibers, which are the axons of hippocampal dentate granule cells
that extend their processes into the inner molecular layer (IML),
the dentate granule cell layer and the CA3 pyramidal cell layer.
Aberrant mossy fiber sprouting was found in the chronically
injured hippocampus (Okazaki et al., 1995; Shetty and Turner,
1997; Shetty et al., 2003). Our results indicated that the mossy
fiber sprouting toward the inner molecular layer significantly
increased in the SE rats compared with that in the normal rats
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Fig. 4. HUMSC transplantation attenuates the activation of neuroglial cells in the hippocampus after pilocarpine-induced SE. Photomicrographs showing the levels of
astrocyte (anti-GFAP, A–C) and microglial cell (anti-ED1, E–H) activities in the normal (A), SE (B) and SE + HUMSC (C) groups at 29 days after SE. (D) Bar graphs showing the
quantified mean value of astrocyte activities in the dorsal hippocampus in the normal, SE and SE + HUMSC groups. Pilocarpine-induced SE elevated significantly astrocyte
activities in CA1, CA3, and the dentate hilus in the SE group (B). Astrocyte activity was prevented by HUMSCs transplantation (C). ED1-positive microglial cells were fewer in
the SE + HUMSC group (g and h, arrows) than those in the SE group (E and F, arrows). * < 0.05, compared to normal rats. #p < 0.05, comparison between SE and SE + HUMSC
groups. Scale bars = 500 lm (A–C); 100 lm (in CA1, CA3, and DH); 10 lm (E–H).
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+ HUMSCs rats, indicating that HUMSC transplantation signifi-
cantly suppressed mossy fiber sprouting after pilocarpine-
induced SE (Fig. 5C).
3.7. Survival and distribution of transplanted HUMSCs in the
hippocampus
To track the migration of the transplanted HUMSCs, their nuclei
were labeled with bisbenzimide. Moreover, anti-human specific
nuclei antigen immunostaining was preformed to detect the
engrafted HUMSCs. Bisbenzimide-labeled HUMSCs survived, and
migrated along the rostrocaudal axis from the implantation site
29 days after transplantation. Large numbers of HUMSCs were
found around the implantation site (Fig. 6A and B). Moreover,
immunostaining showed that most of the engrafted HUMSCs sur-
vived in the hippocampus, and remained near the injection sites
four weeks after transplantation (Fig. 6C and D). The results indi-
cated that the transplanted HUMSCs survived and migrated in
the host hippocampi.3.8. Transplanted HUMSCs remain undifferentiated in the host
hippocampus
To further investigate whether HUMSCs had differentiated into
neuronal cells and astrocytes in rat hippocampus, human NeuN
and GFAP were detected using RT-PCR. Human glioma acted as a
positive control. As shown in Fig. 7A, against the positive detection
of the human brain tissue, neither human NeuN nor GFAP mRNAs
was detectable in the normal, SE, and SE + HUMSCs groups. Our
results indicate that HUMSCs did not differentiate into neurons
or astrocytes.
3.9. Transplanted HUMSCs expressed several cytokines in the rat
hippocampus
To further elucidate the underlying mechanisms of the benefi-
cial effects of HUMSC transplantation, cytokine expressions in
the hippocampal tissues were examined using human cytokine
arrays. The results showed that significantly elevated expressions
of several growth promoting factors were associated with HUMSCs
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Fig. 5. HUMSC transplantation decreases mossy fiber sprouting in the hippocampus after pilocarpine-induced SE. Representative photomicrographs of Timm’s staining
showing mossy fiber sprouting in normal (A), SE (B), and SE + HUMSC (C) groups. Pilocarpine-induced SE led to marked aberrant mossy fiber sprouting in the inner molecular
layer (arrows) of the dentate gyrus, which was attenuated by HUMSCs transplantation. The right panels are magnified images of the left boxed areas in A–C. Scale
bars = 500 lm (A–C); 100 lm (enlarged panel).
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Fig. 6. Photomicrographs showing the survival and migration of grafted HUMSCs in the rat hippocampus. (A) Schematic drawings outline and (B) fluorescence photographs
represent the location of bisbenzimide-labeled HUMSCs (blue dots) in the hippocampus at 29 days after SE at the bregma level. (C and D) Representative coronal sections
show the nuclei of HUMSCs labeled using anti-human specific nuclear antigen in the hippocampus at the bregma level. HUMSCs survived in the hippocampus for 29 days
after transplantation. The panels in D are magnified images of the left boxed areas in C. Arrows in D indicate positively stained cell bodies. Scale bar = 20 lm.
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Fig. 7. HUMSCs released cytokines in the rat hippocampus and in the neuron and HUMSC co-cultures. (A) RT-PCR was performed to detect human NeuN and GFAP mRNA
expression in rat hippocampus. Human NeuN and GFAP mRNAs were not detectable in the SE + HUMSC group. Human glioma cells were used as positive control, where NeuN
and GFAP mRNAs were detected. (B and C) Several growth-promoting human cytokines are significantly increased in the SE + HUMSC group. Photomicrographs of the
NeuroTrace fluorescent Nissl stain in cultured cortical neurons (D), neurons treated with glutamate (E), neuron and HUMSC co-cultures (F), and neuron and HUMSC co-
cultures with glutamate treatment (G). (H) Histograms show that glutamate induced damage in the cortical neurons, and attenuation of glutamate-induced cytotoxicity by
the HUMSC co-culture using an MTT assay. (I and J) Human osteoprotegerin and amphiregulin were detectable in the media of neuron and HUMSC co-cultures. Frames in
blue: MIP-3b, red: GITR, orange: amphiregulin, green: osteoprotegerin, and yellow: FGF-6. * < 0.05, compared with the normal group; #p < 0.05, comparison between the SE
group and SE + HUMSC group (C); * < 0.05, compared with the group of neurons without glutamate treatment; #p < 0.05 compared to the group of neurons with glutamate
treatment (H–J).
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amphiregulin, glucocorticoid-induced tumor necrosis factors
receptor (GITR), MIP-3b, and osteoprotegerin (Fig. 7B and C).3.10. HUMSCs prevented glutamate-induced cytotoxicity in cultured
cortical neurons
Using fluorescent NeuroTrace to label neuronal Nissl bodies,
several cortical neurons were observed in the normal condition
(Fig. 7D). However, the number of NeuroTrace-labeled cell bodies
was reduced significantly after glutamate treatment (Fig. 7E). In
transwell co-cultures of HUMSCs and neurons, there was no signif-
icant change in the number of cortical neurons after treatment
with glutamate (Fig. 7F and G).
The results of an MTT assay revealed that glutamate decreased
cell viability by 58.98 ± 4.84%, compared to that of neurons in the
normal condition. However, the cytotoxic effects of the glutamate
were attenuated by HUMSC co-culture (p < 0.01; Fig. 7H).3.11. Human cytokines were detected in the medium of neurons and
HUMSCs co-culture
To examine the protein levels of cytokine that were released by
HUMSCs, the media from neurons alone or the neuron and HUMSC
co-culture were subjected to human Quantikine ELISA analysis.
Our analysis found abundant amphiregulin and osteoprotegerin
in the medium of neuron and HUMSC co-cultures (Fig. 7I and J).4. Discussion
In the present study, we investigated the potential therapeutic
effects of HUMSCs in a rat pilocarpine-induced SE model. Trans-
planted HUMSCs in the acute phase of excitotoxic brain injury pre-
vented tissue damage in the latent period and suppressed the
development of SRMS.
Several types of cells, including embryonic stem cell and its
derived cells, fetal hippocampal cells, neural stem cells, and bone
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treatment of epilepsy in several experimental models (Acharya
et al., 2008; Chu et al., 2004; Long et al., 2013; Shetty and
Hattiangady, 2007). Boison did not find a seizure prevention effect
for human embryonic stem cells in mice with an intra-amygdaloid
injection of kainic acid (Boison, 2009). In a mouse model of TLE,
Cunningham et al. demonstrated that engrafted hPSC-derived
maturing GABAergic interneurons (mGINs) suppressed sponta-
neous seizure activity. The mGIN-grafted TLE mice showed a sig-
nificantly reduced seizure event frequency. However, the seizure
duration was not significantly different between control TLE mice
and mGIN-grafted TLE mice (Cunningham et al., 2014). In our
video/EEG recording analyses, rats transplanted with HUMSCs
had a longer latency period for developing spontaneous seizure, a
lower seizure frequency, and a shorter seizure duration. Moreover,
seizure activity in all of the animals of the SE + HUMSCs group was
absent entirely at the second and the fourth weeks. These findings
indicate that transplantation of HUMSCs into bilateral hippocampi
ameliorates seizure activity in the rat TLE model.
To determine the brain alterations after pilocarpine-induced SE,
an MRI was performed. Brain edema in the hippocampus, amyg-
dala and piriform cortex was most prominent approximately two
days after SE, which is consistent with a previous finding of vaso-
genic edema due to BBB failure at two days post-SE (Itoh et al.,
2015). In the present study, brain edema in the hippocampus, the
lateral ventricle, the 3rd ventricle, thalamus and piriform cortex
persisted for up to 29 days in the SE group. The temporal profile
is in agreement with the morphological and volume changes in
the dorsal hippocampus after SE. Notably, our results further
showed that HUMSC transplantation did delay and attenuate the
development of SE-induced brain edema.
TLE is characterized by neuronal loss and gliosis in the hip-
pocampus (Borges et al., 2003; do Nascimento et al., 2012). A pre-
vious study used Fluoro-Jade to analyze the temporal pattern of
neuronal damage, and GFAP immunohistochemistry to investigate
gliosis occurring in the hippocampal formation of mice at 3, 6, 12,
and 24 h, and one and three weeks after the pilocarpine-induced
status-epilepticus (SE) onset. The results showed that the maxi-
mum neuronal damage in the hilus of the dentate gyrus appeared
at 3 h after SE onset, and neuronal injury in the CA1 and CA3 pyra-
midal cell appeared at one week after SE onset. The highest pres-
ence of GFAP immunoreaction in CA1 and CA3 was expressed at
one and three weeks after SE onset, respectively (do Nascimento
et al., 2012). Many studies have examined the effects of SRMS
and multiple epileptogenic changes in chronically injured hip-
pocampus, including aberrant mossy fibers sprouting (Okazaki
et al., 1995; Shetty and Turner, 1997; Shetty et al., 2003), the loss
of calbindin (Shetty and Turner, 1995), and reductions in the num-
ber of GABAergic interneurons (Esclapez et al., 1997; Franck et al.,
1988; Mathern et al., 1995; Shetty and Turner, 2000; Sloviter and
Nilaver, 1987). In our study, brain edema reached a plateau at
15 days after pilocarpine treatment and persisted up to 29 days
in the SE group. In agreement with the evidence from MRI images,
Nissl staining results showed that the morphology of the dorsal
hippocampus was abnormal, and the dorsal hippocampal volume
in the SE group was significantly decreased. Moreover, quantitative
calculation of pyramidal neurons and GABAergic neurons in the
hippocampus demonstrated that the number of pyramidal neuron
and GABAergic neurons was decreased significantly in the CA1 and
CA3 regions in the SE group at Day 29 after SE. In our present study,
the extent of the SE-induced loss of hippocampal pyramidal and
GABAergic neurons was significantly reduced by HUMSCs trans-
plantation. The results suggest that the suppression of SRMS might
underlie the reduction in brain edema, preservation of pyramidal
cells and GABAergic inhibitory interneuron circuitry.GFAP is a risk marker of acute injury and astrogliosis (Gurnett
et al., 2003). Several authors have suggested that astrocytes might
have an important role in the generation and spread of seizure
activity (Hammer et al., 2008; Seifert and Steinhauser, 2013). The
reactive astrocytes during the process of epileptogenesis might
be associated with the release of trophic factors that lead to axonal
sprouting, synapse formation, and hyper-excitability (O’Dell et al.,
2012). In the present study, GFAP positive cells were increased in
CA1, CA3 and dentate gyrus. This result provides evidence of pos-
sible positive functions of grafted HUMSCs in a TLE animal model.
HUMSCs might inhibit SE-induced brain inflammation.
Lee and coworkers found that the frequency and the duration of
spontaneous recurrent motor seizures in pilocarpine-induced ani-
mals were reduced by the transplantation of human neural stem/
progenitor cells (NSPCs) into the hippocampus (Lee et al., 2014).
The effect was likely due to the differentiation of human NSPCs
into GABAergic interneurons. Bone marrow mesenchymal stem
cells (BMSCs) or genetically engineered BMSCs were injected intra-
venously, transplanted intra-ventricularly, or implanted directly
into the hippocampus to evaluate the recovery of pilocarpine-
induced epileptic rats. The results showed that the number of sei-
zures significantly decreased, and the density of neurons per area
was higher in the transplanted group (Abdanipour et al., 2011;
Costa-Ferro et al., 2012, 2010; Huicong et al., 2013; Leal et al.,
2014; Li et al., 2009; Long et al., 2013). Regarding human cord
blood, transplantation of HUCBC into pilocarpine-induced epileptic
rats protected against neuronal loss in the hippocampal subfields
CA1, CA3, and in the hilus of the dentate gyrus. Moreover, the fre-
quency and duration of spontaneous recurrent seizures after SE
were reduced in transplanted rats (Leal et al., 2014).
In addition to neuronal protection, therapeutic stem cell trans-
plantation also improves neurogenesis (Shetty, 2012). A previous
study showed that chronic TLE was associated with a severe
decrease of neurogenesis in the adult hippocampus (Hattiangady
et al., 2004). Other studies showed that the implantation of neu-
ronal stem cells or progenitors into the hippocampus of aged rats
stimulated neurogenesis from endogenous neuronal stem cells in
the dentate gyrus (Hattiangady et al., 2007; Park et al., 2010).
These results reveal that stem cell transplantation to improve the
neurogenesis may become a promising therapeutic approach. Most
likely, the cytokine release from stem cells critically influences
neurogenesis. In our present study, the SE-induced loss of hip-
pocampal pyramidal and GABAergic neurons was significantly
reduced by HUMSCs transplantation. Our results indicate that
HUMSC implantation may provide supplemental neuronal protec-
tion and stimulate neurogenesis.
Ideal donor cells for neurological disease therapy should have
the following characteristics: (i) be easily available; (ii) be capable
of rapid expansion in culture; (iii) be immunologically compatible;
(iv) be capable of long-term survival and integration in the host tis-
sue, and (v) be amenable to stable transfection and long-term
expression of exogenous genes (Bjorklund, 1993). HUMSCs in
Wharton’s jelly of the umbilical cord can be easily obtained and
processed compared to embryonic or bone marrow stem cells.
Approximately 1  106 HUMSCs were collected from a 20-cm
umbilical cord. The number of HUMSCs doubled (2  106) in 10%
fetal bovine serum (FBS)-Dulbecco’s modified Eagle’s medium
(DMEM) in three days. Our previous studies have shown that the
transformed HUMSCs in the striatum were still viable four months
after transplantation without the need for immunological suppres-
sion (Fu et al., 2006). Moreover, transformed HUMSCs survived in
the rat liver and were able to control Type 1 Diabetes (Chao
et al., 2008). Likewise, the HUMSCs in the present study survived
in rat spinal cords, suggesting that HUMSCs are an ideal stem cell
source for transplantation.
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engrafted into fibrotic liver, infarct cortex or the injured spinal cord
depending on the different pathological microenvironments (Lin
et al., 2011; Tsai et al., 2009; Yang et al., 2008). We previously
showed that transplantation of HUMSCs could serve as a therapeu-
tic option for ischemic stroke. Implanted HUMSCs released
neuroprotective and growth-associated cytokines including
neutrophil-activating protein-2 (NAP-2), angiopoietin-2, brain-
derived neurotrophic factor (BDNF), CXCL-16 and platelet-derived
growth factor-AA (PDGF-AA). These cytokines can promote
endogenous neurogenesis, protect neurons from damage, and
improve motor function after ischemic stroke, and therefore con-
tribute to the overall therapeutic effects of HUMSC transplantation
(Lin et al., 2011). Interestingly, HUMSCs release different cytokines
according to the different organs in which they are grafted. When
HUMSCs are implanted into the rat spinal cord after complete tran-
section, instead of differentiating into neurons, astrocytes, or oligo-
dendrocytes, they release human cytokines and growth factors
such as neurotrophin-3, NAP-2, basic fibroblast growth factor
(bFGF), GITR, and vascular endothelial growth factor receptor 3
(VEGF-R3), which may be involved in the repair and regeneration
of the spinal cord (Yang et al., 2008). Furthermore, without differ-
entiating into hepatocytes, HUMSCs grafted into rat fibrotic liver
release a considerable amount of human prolactin, leukemia inhi-
bitory factor (LIF), and cutaneous T cell-attracting chemokine
(CTACK) (Tsai et al., 2009). Therefore, depending on the pathophysi-
ological microenvironment, it is likely that HUMSCs release different
cytokines and respond accordingly.
The expression of 174 human cytokines was measured in this
study, including pro-inflammatory cytokines such as IL-1, IL-6,
and TNF-a (De Simoni et al., 2000; Grall et al., 2003). We found that
the amount of human pro-inflammatory cytokines did not change
in the SE + HUMSC group relative to those of the normal and SE
groups. Nevertheless, five human cytokines or growth factors were
increased in the hippocampi of the SE + HUMSC group, which were
FGF-6, amphiregulin, GITR, MIP-3b, and osteoprotegerin. These
cytokines may execute various functions and play distinct roles.
Above all, MIP-3b may enhance the production of anti-
inflammatory cytokine IL-10 by activated human peripheral blood
monocytes and T cells, suggesting that MIP-3b could participate in
anti-inflammatory activity (Byrnes et al., 1999). Extracellular-
signal-regulated kinase (ERK) phosphorylation and NANOG are
critically involved with self-renewal, proliferation, and undifferen-
tiation in pluripotent embryonic stem cells (Chen et al., 2012;
Mitsui et al., 2003). FGF-6 treatment could sustain NANOG expres-
sion levels and support ERK phosphorylation in ESCs (Chen et al.,
2012). Moreover, MIP-3b could induce ERK phosphorylation in a
dose-dependent fashion (Yu et al., 2015). In this study, human
FGF-6 and MIP-3b were up-regulated in the SE + HUMSC group,
suggesting that FGF-6 and MIP-3b expression in HUMSCs in the
host hippocampi may help to maintain their undifferentiated state
and release of cytokines. This observation was consistent with the
RT-PCR results, neither human NeuN nor GFAP mRNAs were
detectable in the SE + HUMSC group, indicating that HUMSCs did
not differentiate into neurons or astrocytes. Previous studies have
shown that MIP-3b could promote cell proliferation, cell invasion,
and cell migration (Peng et al., 2015; Yu et al., 2015). Amphiregulin
stimulates axonal outgrowth, and act as a neuronal survival factor
(Falk and Frisen, 2002; Nilsson and Kanje, 2005). GITR is important
for neuronal development. Activation of GITR could inhibit the
nuclear factor-kappaB signal pathway, and regulate the extent of
sympathetic neurite growth (McKelvey et al., 2012). Osteoprote-
gerin plays a neuroprotection role in the cochlear nerve (Kao
et al., 2013). From our results, human cytokines released from
HUMSCs might be involved in processes of neuroprotection and
anti-inflammation after transplantation into pilocarpine-inducedepilepsy rats. Our in vitro results support a similar conclusion.
Our results demonstrate that treatment of cultured cortical
neurons with glutamate caused neuronal damage; however,
co-culturing with HUMSCs might prevent such neuronal loss.
Furthermore, large quantities of amphiregulin and osteoprotegerin
were present in the medium of the neuron and HUMSC co-cultures.
5. Conclusion
Our study shows that intra-hippocampal transplantation of
HUMSCs can suppress the spontaneous recurrent seizures in a pilo-
carpine TLE model. The underlying mechanisms of the early thera-
peutic effects include a decrease of neuron and interneuron loss,
suppression of SE-induced brain inflammation, and a reduction of
MFS. Our results suggest that cytokines released from transplanted
HUMSCs are neuroprotective against epileptogenesis.
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